Heidi Health
Category: AI in Healthcare
AI medical scribe platform that automates clinical documentation and administrative tasks for clinicians Heidi Health was founded in 2019. The company is led by Dr. Thomas Kelly. Based in Melbourne, Australia. Team size: 500+. Total funding raised: $96.6M. Latest round: Series B. Key investors include Point72 Private Investments, Blackbird Ventures, Headline, Latitude, Archangel Ventures, Possible Ventures, January Capital, HESTA, LocalGlobe, Anthology (Menlo Ventures / Anthropic).
- Founded
- 2019
- Headquarters
- Melbourne, Australia
- Team size
- 500+
- Total funding
- $96.6M
Value proposition
Reduces administrative burden for clinicians by 30-50%, saves 18M+ hours of documentation time, and improves patient care through AI-driven automation
Products and solutions
AI Medical Scribe (ambient transcription and note-taking), Pre-chart summaries, Clinical guideline lookups, Automated form filling, Patient outreach tools, EHR integration, Heidi Evidence (clinical decision support with citations), Heidi Comms (AI-powered patient communications), Heidi Remote (wearable offline mic), Heidi Dictate (cursor-guided clinical voice dictation across apps)
Unique value
Focus on user-centric customization with templates matching clinicians' styles, global scalability from day one, and seamless ambient AI workflows avoiding clunky EHR integrations
Target customer
Clinicians, GPs, hospitals, and healthcare systems including NHS Trusts, Beth Israel Lahey Health, and Australian health systems
Industries served
Primary care, Hospital systems, Telehealth, Mental health, Allied health, Veterinary medicine, Global healthcare (UK NHS, US, Australia, New Zealand, Canada)
Technology advantage
Proprietary AI model with real-time transcription engine optimized for clinical jargon, HIPAA-grade cloud architecture, and multilingual natural-language understanding trained on millions of clinical dialogue snippets
How they differentiate
Heidi differentiates through ambient listening technology and end-to-end automation of clinical documentation, with proprietary real-time transcription optimized for clinical jargon, whereas competitors rely on legacy speech engines or fragmented integrations
Main competitors
DeepScribe, Ambience Healthcare, Abridge, Nuance Dragon Medical, Suki, Robin Healthcare
Key partnerships
Vim (EHR integration), NHS Innovation Fund, Point72 Private Investments, Blackbird Ventures, Headline, Latitude, Best Practice Software, R1 RCM (revenue cycle management), HealthPathways, EMGuidance, MIMS, Vidal, NICE, BMJ Group, Anthropic (Claude models for Evidence)
Notable customers
NHS (National Health Service), Beth Israel Lahey Health (system-wide, ~6,000 providers), MaineGeneral Health, Monash Health, Queensland Health Children's Hospital, Royal Children's Hospital (Melbourne), Yukon Government, Eucalyptus, Icon Group, Cabrini Health, Mater Health, Nabta (UAE)
Major milestones
$65M Series B funding in October 2025, 18 million hours returned to frontline clinicians, 100M+ clinical interactions globally, 2.7M+ weekly consults across 190 countries, Recognition as Becker's Health IT & Revenue Cycle Up-and-Comer for 2025, Launch of Heidi Evidence and Heidi Comms (Feb 2026), Acquisition of UK-based AutoMedica (Feb 2026), Strategic partnership with R1 RCM (March 2026), $50M ARR milestone (April 2026), $465M USD / ~$660M AUD valuation (Series B), Beth Israel Lahey Health system-wide rollout to ~6,000 providers (May 2026), Royal Children's Hospital Melbourne deployment (June 2026)
Growth metrics
18M+ hours returned to clinicians, 100M+ clinical interactions globally, 2.7M+ weekly consults across 110 languages in 190 countries, serving clinicians in 50+ countries
Market positioning
Positioned as an AI 'care partner' for clinicians globally, focusing on both private clinics and public healthcare providers with emphasis on making core features free and self-serve onboarding
Geographic focus
Primary markets in Australia (headquarters), United States, United Kingdom, and Canada, with expansion into European healthcare via NHS; Middle East/GCC via Dubai HQ; Asia (Singapore, Hong Kong); South Africa
Patents and IP
No publicly disclosed patents; innovation is primarily in proprietary AI workflows and user experience design
About Dr. Thomas Kelly
Former vascular surgical resident with expertise in medical AI and healthcare innovation. Previously co-founded Oscer (AI medical training platform) and has background in mathematics and deep learning.
More AI in Healthcare companies
Official website: https://www.heidihealth.com
